Monitor Longevity's future net sales disclosures and capital events for mandatory prepayment triggers; the agreement provides visibility into PMGC's non-dilutive cash flow stream through 2031.
Price Chart
Executive Summary
PMGC Holdings entered a payment agreement with Longevity Health Holdings converting its 5% net sales royalty from the Elevai Skincare divestiture into scheduled monthly cash payments through August 2031. The agreement secures a $94,937 acknowledged 2025 royalty with interest, plus all future royalties, providing PMGC with recurring, non-dilutive cash flow and creditor-grade enforcement rights.
Key Financial Metrics
Key Facts
- Payment agreement converts 5% net sales royalty from Elevai Skincare sale into monthly installments of $10,000 starting October 15, 2026, with all amounts due by August 28, 2031
- Longevity acknowledged $94,937 in 2025 royalty obligation with interest at WSJ Prime Rate + 1.00% per annum from April 2026 due date
- Mandatory prepayments of 15% of net cash proceeds from qualifying capital raises >$350,000, asset sales, settlements, or insurance recoveries
- Payment obligations are absolute, unconditional, and joint and several with the Elevai Skincare buyer
- Annual net sales statements due within 5 business days of Longevity's 10-K filing, with annual audit rights
- All future royalty and earnout payments automatically added to the payment plan on same interest-bearing terms
Financial Impact
$94,937 acknowledged 2025 royalty plus interest, with $10,000/month minimum payments through 2031; total value depends on future Elevai Skincare net sales
Risk Factors
- Longevity or the Elevai Skincare buyer may default on payment obligations, triggering acceleration and enforcement rights
- Actual royalty payments depend on Elevai Skincare product line commercial performance, which is uncertain
- Mandatory prepayment triggers are limited to capital events exceeding $350,000, which may not occur frequently
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3364668 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 27d ago | Press Release | $3.67 $3.54 | ▼ −3.54% | ▼ −3.34% | $2.61 (−28.88%) |
Sep 18, 2026 5w ago | 8-K | $4.78 $4.42 | ▼ −7.53% | ▼ −9.08% | $2.61 (−45.40%) |
Sep 18, 2026 5w ago | Press Release | $4.78 $4.42 | ▼ −7.53% | ▼ −9.08% | $2.61 (−45.40%) |
Aug 19, 2026 9w ago | Press Release | $0.5603 $0.6100 | ▲ +8.87% | ▲ +9.71% | $2.61 (+365.82%) |
Aug 14, 2026 10w ago | Press Release | $0.9100 $0.8730 | ▼ −4.07% | ▼ −3.59% | $2.61 (+186.81%) |
Jul 29, 2026 12w ago | Press Release | $0.8800 $0.9493 | ▲ +7.88% | ▲ +6.20% | $2.61 (+196.59%) |
Jul 9, 2026 15w ago | 8-K | $1.12 $1.09 | ▼ −2.68% | ▼ −1.91% | $2.61 (+133.04%) |
Jul 1, 2026 16w ago | 8-K | $1.28 $1.18 | ▼ −7.81% | ▼ −7.68% | $2.61 (+103.91%) |
Jun 8, 2026 20w ago | Press Release | $1.59 $1.41 | ▼ −11.32% | ▼ −11.03% | $2.61 (+64.15%) |
Jun 5, 2026 20w ago | 8-K | $1.59 $1.41 | ▼ −11.32% | ▼ −11.03% | $2.61 (+64.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers